TABLE 2.
Agonist-like effect of anti-TcP2β C terminus antibodiesa
| Mouse group | Purified antibodies | Antibodies + bisoprolol | Antibodies + atropine |
|---|---|---|---|
| Control | 1.08 ± 0.88 | NDb | 0.4 ± 0.92 |
| B1 | 2.2 ± 1.16 | ND | 2.0 ± 1.24 |
| C1 | 12.8 ± 1.32 | 0.6 ± 1.16 | 18 ± 1.56 |
| C2 | 16.6 ± 1.36 | 0.6 ± 1.56 | 21.2 ± 1.4 |
| D1 | 20.8 ± 1.04 | 12 ± 1.12 | 26.8 ± 1.04 |
Anti-TcP2β IgGs from sera were selected from GST–TcP2β–Alu-Gel-S (group B)- or Hist-TcP2β-CFA (group C)-immunized mice and chronically T. cruzi-infected mice (group D). The increase in beating frequency per minute was determined, and the mean ± standard error of the mean of 10 different measurements is shown. Bisoprolol (1 μM) and atropine (1 μM) were added in different experiments.
ND, not done.